http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-075935-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f834ce5e3653300cfeee6fc9f68468f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
filingDate 2010-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef179148d930e338e6b54d981e88ba3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe4c656eb6e751be5c51d2e193a771d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fda843b2431771218c80e0814c509a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_762d448965b097cfcf56c62389fa7619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d469e25b25305f43defbfe477456ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfa699c4ec996fcfd1daca49509d4ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e980f0e7a63117ae740658936c938a10
publicationDate 2011-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-075935-A1
titleOfInvention DERIVATIVES OF QUINOXALINE AND ITS USE FOR THE TREATMENT OF BENIGN AND EVIL TUMORS
abstract Claim 1: Quinoxaline derivatives characterized in that they have the general formula 1 in which X is: oxygen or sulfur; R1 is hydrogen, substituted or unsubstituted C1-12 alkyl, cyano, halogen, R2 / R3 are hydrogen, substituted or unsubstituted C1-12 alkyl, R4 is hydrogen, substituted or unsubstituted C1-12 alkyl, unsubstituted or substituted cycloalkyl , unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted alkylaryl, unsubstituted or substituted alkylheteroaryl, and R5-R8 are hydrogen, substituted or unsubstituted C1-12 alkyl, unsubstituted aryl or substituted, unsubstituted or substituted heteroaryl, halogen, cyano, hydroxyl, C1-12 alkoxy, amino, carboxyl, alkoxycarbonyl, carboxyalkyl or alkoxycarbonylalkyl, alkoxycarbonylamino, alkoxycarbonylaminoalkyl, and with the proviso that at least one of the R5-R8 substituents is an unsubstituted or substituted aryl or radical heteroaryl, and where the substituents are selected from the group consisting of F, Cl, Br, I, CN, CF3, NH2, NH-alkyl, NH-aryl, N (al chyl) 2, NH-CO-alkyl, NH-CO-aryl, NH-CO-heteroaryl, NH-SO2-alkyl, NH-SO2-aryl, NH-SO2-heteroaryl, NH-CO-NH-alkyl, NH- CO-NH-aryl, NH-CO-NH-heteroaryl, NH-C (O) O-alkyl, NH-C (O) O-aryl, NH-C (O) O-heteroaryl, NO2, SH, S- alkyl, OH, OCF3, O-alkyl, O-aryl, O-CO-alkyl, O-CO-aryl, O-CO-heteroaryl, OC (O) O-alkyl, OC (O) O-aryl, OC ( O) O-heteroaryl, O-CO-NH-alkyl, O-CO-N (alkyl) 2, O-CO-NH-aryl, O-CO-NH-heteroaryl, OSO3H, OSO2-alkyl, OSO2-aryl, OSO2-heteroaryl, OP (O) OH) 2, alkyl-P (O) (OH) 2CHO, CO2H, C (O) O-alkyl, C (O) O-aryl, C (O) O-heteroaryl, CO -alkyl, CO-aryl, CO-heteroaryl, SO3H, SO2-NH2, SO2-NH-alkyl, SO2-NH-aryl, SO2-NH-heteroaryl, alkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, where the alkyl alkyl radicals, "Cycloalkyl", "heterocyclyl", "aryl" and "heteroaryl" may also be substituted, their physiologically acceptable salts, hydrates and solvates, where the compounds of the general formula (1) and their salts, hydrates or solv Atos may be present in the form of their racemates, enantiomers and / or diastereomers, or in the form of mixtures of their enantiomers and / or diastereomers, in the form of tautomers and their polymorphic forms.
priorityDate 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457703603

Total number of triples: 32.